secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2023-03-14T23:59:59+00:00
Accession:  0001213900-23-019971
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx announces $15M stock buyback program through March 2024
------------------------------------------------------------------

- Board authorized repurchase of up to $15M of common stock.
- Program expires March 12, 2024 or when $15M of repurchases completed.
- Repurchases may be made in open market or privately negotiated transactions.
- Company plans to finance purchases using available cash and cash equivalents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390023019971/0001213900-23-019971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390023019971/ea175219-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-019971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer